nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Vertigo—Vincristine—muscle cancer	0.00311	0.00311	CcSEcCtD
Letrozole—Leukopenia—Vincristine—muscle cancer	0.0031	0.0031	CcSEcCtD
Letrozole—Erythema multiforme—Etoposide—muscle cancer	0.00305	0.00305	CcSEcCtD
Letrozole—Rash maculo-papular—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Letrozole—Anorexia—Dactinomycin—muscle cancer	0.00302	0.00302	CcSEcCtD
Letrozole—Eye disorder—Etoposide—muscle cancer	0.00301	0.00301	CcSEcCtD
Letrozole—Neoplasm—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Letrozole—Flushing—Etoposide—muscle cancer	0.00299	0.00299	CcSEcCtD
Letrozole—Cardiac disorder—Etoposide—muscle cancer	0.00299	0.00299	CcSEcCtD
Letrozole—Hypertension—Vincristine—muscle cancer	0.00299	0.00299	CcSEcCtD
Letrozole—Myalgia—Vincristine—muscle cancer	0.00295	0.00295	CcSEcCtD
Letrozole—Angiopathy—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Letrozole—Mediastinal disorder—Etoposide—muscle cancer	0.00291	0.00291	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00288	0.00288	CcSEcCtD
Letrozole—Alopecia—Etoposide—muscle cancer	0.00285	0.00285	CcSEcCtD
Letrozole—Cerebrovascular accident—Methotrexate—muscle cancer	0.00285	0.00285	CcSEcCtD
Letrozole—Lethargy—Methotrexate—muscle cancer	0.00285	0.00285	CcSEcCtD
Letrozole—Oedema—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Letrozole—Anaphylactic shock—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Letrozole—Infection—Vincristine—muscle cancer	0.00281	0.00281	CcSEcCtD
Letrozole—Phlebitis—Doxorubicin—muscle cancer	0.00281	0.00281	CcSEcCtD
Letrozole—Thrombophlebitis—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Letrozole—Nervous system disorder—Vincristine—muscle cancer	0.00277	0.00277	CcSEcCtD
Letrozole—Decreased appetite—Dactinomycin—muscle cancer	0.00275	0.00275	CcSEcCtD
Letrozole—Dysgeusia—Etoposide—muscle cancer	0.00275	0.00275	CcSEcCtD
Letrozole—Hyperhidrosis—Vincristine—muscle cancer	0.00273	0.00273	CcSEcCtD
Letrozole—Fatigue—Dactinomycin—muscle cancer	0.00273	0.00273	CcSEcCtD
Letrozole—Back pain—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Letrozole—Pain—Dactinomycin—muscle cancer	0.00271	0.00271	CcSEcCtD
Letrozole—Anorexia—Vincristine—muscle cancer	0.0027	0.0027	CcSEcCtD
Letrozole—Irritability—Methotrexate—muscle cancer	0.00266	0.00266	CcSEcCtD
Letrozole—Feeling abnormal—Dactinomycin—muscle cancer	0.00261	0.00261	CcSEcCtD
Letrozole—Ill-defined disorder—Etoposide—muscle cancer	0.0026	0.0026	CcSEcCtD
Letrozole—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00259	0.00259	CcSEcCtD
Letrozole—Hot flush—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00258	0.00258	CcSEcCtD
Letrozole—Increased appetite—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Letrozole—Menopausal symptoms—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Letrozole—Insomnia—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Letrozole—Paraesthesia—Vincristine—muscle cancer	0.00254	0.00254	CcSEcCtD
Letrozole—Malaise—Etoposide—muscle cancer	0.00253	0.00253	CcSEcCtD
Letrozole—Breast disorder—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Letrozole—Vertigo—Etoposide—muscle cancer	0.00252	0.00252	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Letrozole—Leukopenia—Etoposide—muscle cancer	0.00251	0.00251	CcSEcCtD
Letrozole—Abdominal pain—Dactinomycin—muscle cancer	0.0025	0.0025	CcSEcCtD
Letrozole—Body temperature increased—Dactinomycin—muscle cancer	0.0025	0.0025	CcSEcCtD
Letrozole—Cardiac failure—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Letrozole—Lethargy—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Letrozole—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Letrozole—Decreased appetite—Vincristine—muscle cancer	0.00246	0.00246	CcSEcCtD
Letrozole—Cough—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Letrozole—Gastrointestinal disorder—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Letrozole—Fatigue—Vincristine—muscle cancer	0.00244	0.00244	CcSEcCtD
Letrozole—Hypertension—Etoposide—muscle cancer	0.00242	0.00242	CcSEcCtD
Letrozole—Constipation—Vincristine—muscle cancer	0.00242	0.00242	CcSEcCtD
Letrozole—Pain—Vincristine—muscle cancer	0.00242	0.00242	CcSEcCtD
Letrozole—Pain in extremity—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Letrozole—Chest pain—Etoposide—muscle cancer	0.00239	0.00239	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00237	0.00237	CcSEcCtD
Letrozole—Discomfort—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Letrozole—Gastrointestinal pain—Vincristine—muscle cancer	0.00231	0.00231	CcSEcCtD
Letrozole—Anaphylactic shock—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Letrozole—Infection—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Letrozole—Asthenia—Dactinomycin—muscle cancer	0.00227	0.00227	CcSEcCtD
Letrozole—Tachycardia—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Letrozole—Abdominal pain—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Letrozole—Body temperature increased—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Letrozole—Skin disorder—Etoposide—muscle cancer	0.00223	0.00223	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Letrozole—Hyperhidrosis—Etoposide—muscle cancer	0.00221	0.00221	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Letrozole—Anorexia—Etoposide—muscle cancer	0.00218	0.00218	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Letrozole—Diarrhoea—Dactinomycin—muscle cancer	0.00217	0.00217	CcSEcCtD
Letrozole—Infestation—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Letrozole—Infestation NOS—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Letrozole—Depression—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Letrozole—Stomatitis—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Letrozole—Influenza—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Letrozole—Sweating—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Letrozole—Paraesthesia—Etoposide—muscle cancer	0.00206	0.00206	CcSEcCtD
Letrozole—Dyspnoea—Etoposide—muscle cancer	0.00204	0.00204	CcSEcCtD
Letrozole—Somnolence—Etoposide—muscle cancer	0.00204	0.00204	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Letrozole—Asthenia—Vincristine—muscle cancer	0.00203	0.00203	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—muscle cancer	0.00201	0.00201	CcSEcCtD
Letrozole—Rash—Dactinomycin—muscle cancer	0.002	0.002	CcSEcCtD
Letrozole—Decreased appetite—Etoposide—muscle cancer	0.00199	0.00199	CcSEcCtD
Letrozole—Gastrointestinal disorder—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Letrozole—Fatigue—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Letrozole—Constipation—Etoposide—muscle cancer	0.00196	0.00196	CcSEcCtD
Letrozole—Pain—Etoposide—muscle cancer	0.00196	0.00196	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—muscle cancer	0.00194	0.00194	CcSEcCtD
Letrozole—Diarrhoea—Vincristine—muscle cancer	0.00193	0.00193	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Letrozole—Feeling abnormal—Etoposide—muscle cancer	0.00189	0.00189	CcSEcCtD
Letrozole—Nausea—Dactinomycin—muscle cancer	0.00188	0.00188	CcSEcCtD
Letrozole—Gastrointestinal pain—Etoposide—muscle cancer	0.00187	0.00187	CcSEcCtD
Letrozole—Dizziness—Vincristine—muscle cancer	0.00187	0.00187	CcSEcCtD
Letrozole—Infestation—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Letrozole—Urticaria—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Letrozole—Vomiting—Vincristine—muscle cancer	0.0018	0.0018	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Letrozole—Sweating—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Letrozole—Rash—Vincristine—muscle cancer	0.00178	0.00178	CcSEcCtD
Letrozole—Dermatitis—Vincristine—muscle cancer	0.00178	0.00178	CcSEcCtD
Letrozole—Headache—Vincristine—muscle cancer	0.00177	0.00177	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Letrozole—Alopecia—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Letrozole—Nausea—Vincristine—muscle cancer	0.00168	0.00168	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—muscle cancer	0.00166	0.00166	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Asthenia—Etoposide—muscle cancer	0.00164	0.00164	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Letrozole—Back pain—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Letrozole—Pruritus—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—muscle cancer	0.00158	0.00158	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Letrozole—Flushing—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Letrozole—Malaise—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Letrozole—Dizziness—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Letrozole—Vertigo—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Letrozole—Cough—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Letrozole—Vomiting—Etoposide—muscle cancer	0.00146	0.00146	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Letrozole—Rash—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Letrozole—Dermatitis—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Letrozole—Headache—Etoposide—muscle cancer	0.00144	0.00144	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Letrozole—Chest pain—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Letrozole—Myalgia—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Letrozole—Tension—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Letrozole—Discomfort—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Letrozole—Back pain—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Letrozole—Infection—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Letrozole—Nausea—Etoposide—muscle cancer	0.00136	0.00136	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—muscle cancer	0.00133	0.00133	CcSEcCtD
Letrozole—Malaise—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Anorexia—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Letrozole—Cough—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Letrozole—Insomnia—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Letrozole—Somnolence—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Letrozole—Oedema—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Letrozole—Fatigue—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Letrozole—Infection—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Letrozole—Pain—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—muscle cancer	0.00115	0.00115	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Letrozole—Urticaria—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Letrozole—Pain—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Letrozole—Constipation—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Letrozole—Asthenia—Methotrexate—muscle cancer	0.000984	0.000984	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—muscle cancer	0.000979	0.000979	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Letrozole—Pruritus—Methotrexate—muscle cancer	0.000971	0.000971	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—muscle cancer	0.000944	0.000944	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—muscle cancer	0.000939	0.000939	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—muscle cancer	0.000939	0.000939	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—muscle cancer	0.000939	0.000939	CcSEcCtD
Letrozole—Dizziness—Methotrexate—muscle cancer	0.000907	0.000907	CcSEcCtD
Letrozole—Vomiting—Methotrexate—muscle cancer	0.000872	0.000872	CcSEcCtD
Letrozole—Rash—Methotrexate—muscle cancer	0.000865	0.000865	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—muscle cancer	0.000864	0.000864	CcSEcCtD
Letrozole—Headache—Methotrexate—muscle cancer	0.00086	0.00086	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—muscle cancer	0.000852	0.000852	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—muscle cancer	0.000841	0.000841	CcSEcCtD
Letrozole—Nausea—Methotrexate—muscle cancer	0.000815	0.000815	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—muscle cancer	0.000813	0.000813	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—muscle cancer	0.000786	0.000786	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—muscle cancer	0.000755	0.000755	CcSEcCtD
Letrozole—Rash—Doxorubicin—muscle cancer	0.000749	0.000749	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—muscle cancer	0.000748	0.000748	CcSEcCtD
Letrozole—Headache—Doxorubicin—muscle cancer	0.000744	0.000744	CcSEcCtD
Letrozole—Nausea—Doxorubicin—muscle cancer	0.000706	0.000706	CcSEcCtD
